A meta-analysis comparing GDM-affected women treated with glyburide versus insulin did not find differences in adverse perinatal outcomes, but a more recent meta-analysis found that neonates exposed in utero to glyburide have a higher incidence of hypoglycaemia [214,215]. Here, INS is linked to gestational diabetes.